Is the polarity of relapse/recurrence in bipolar-I disorder patients related to serum lithium levels? Results from an empirical study

Journal of Affective Disorders

Volumn 115, Issue 3, 2009, Pages 466-470

  Severus, W E ^a   Kleindienst, N ^b   Evoniuk, G ^c   Bowden, C ^d   Moller H J ^a   Bohus, M ^b   Frangou, S ^e   Greil, W ^a   Calabrese, J R ^f  

^a UNIVERSITY OF MUNICH   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

^c GLAXOSMITHKLINE   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e KING'S COLLEGE LONDON   (United Kingdom)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorders; Lithium; Maintenance treatment

Indexed keywords

LAMOTRIGINE; LITHIUM; PLACEBO;

ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; HUMAN; HYPOMANIA; LITHIUM BLOOD LEVEL; MANIA; MENTAL DISEASE; MIXED MANIA AND DEPRESSION; MONOTHERAPY; MOOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECURRENT DISEASE; RELAPSE;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; BLOOD CHEMICAL ANALYSIS; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LITHIUM; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 67349147896     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2008.10.009     Document Type: Article

References (19)

1. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am. J. Psychiatry 159 (2002) 1-50
2. Coppen A., Abou-Saleh M., Milln P., Bailey J., and Wood K. Decreasing lithium dosage reduces morbidity and side-effects during prophylaxis. J. Affect. Disord. 5 (1983) 353-362
3. Einat H., and Manji H.K. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol. Psychiatry 59 (2006) 1160-1171
4. Faria M.S., and Teixeira N.A. Reversal of learned helplessness by chronic lithium treatment at a prophylactic level. Braz. J. Med. Biol. Res. 26 (1993) 1201-1212
5. Frye M.A., Yatham L.N., Calabrese J.R., Bowden C.L., Ketter T.A., Suppes T., Adams B.E., and Thompson T.R. Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trials. J. Clin. Psychiatry 67 (2006) 1721-1728
6. Gelenberg A.J., Kane J.M., Keller M.B., Lavori P., Rosenbaum J.F., Cole K., and Lavelle J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N. Engl. J. Med. 321 (1989) 1489-1493
7. Goodwin G.M., Bowden C.L., Calabrese J.R., Grunze H., Kasper S., White R., Greene P., and Leadbetter R. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J. Clin. Psychiatry 65 (2004) 432-441
8. Grunze H., Kasper S., Goodwin G., Bowden C., Möller H.J., and WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J. Biol. Psychiatry 5 (2004) 120-135
9. Hullin R.P. Minimum serum lithium levels for effective prophylaxis. In: Johnson F.N. (Ed). Handbook of Lithium Therapy (1980), MTP Press Limited, Lancaster 243-247
10. Jerram T.C., and McDonald R. Plasma lithium control with particular reference to minimum effective plasma levels. In: Johnson F.N., and Johnson S. (Eds). Lithium in Medical Practice (1978), MTP Press, Lancaster 407-413
11. Kleindienst N., Severus W.E., Möller H.J., and Greil W. Is polarity of recurrence related to serum lithium level in patients with bipolar disorder?. Eur. Arch. Psychiatry Clin. Neurosci. 255 (2005) 72-74
12. Kleindienst N., Severus W.E., and Greil W. Are serum lithium levels related to the polarity of recurrence in bipolar disorders? Evidence from a multicenter trial. Int. Clin. Psychopharmacol. 22 (2007) 125-131
13. Kukopoulos A., Minnai G., and Müller-Oerlinghausen B. The influence of mania and depression on the pharmacokinetics of lithium. A longitudinal single-case study. J. Affect. Disord. 8 (1985) 159-166
14. Licht R.W., Vestergaard P., Kessing L.V., Larsen J.K., Thomsen P.H., and Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Psychopharmacological treatment with lithium and antiepileptic drugs: suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark. Acta Psychiatr. Scand., Suppl. 419 (2004) 1-22
15. Maj M., Starace F., Nolfe G., and Kemali D. Minimum plasma lithium levels required for effective prophylaxis in DSM III bipolar disorder: a prospective study. Pharmacopsychiatry 19 (1986) 420-423
16. Severus W.E., Kleindienst N., Seemüller F., Frangou S., Möller H.J., and Greil W. What is the optimal serum lithium level in the long-term treatment of bipolar disorder - a review?. Bipolar Disord. 10 (2008) 231-237
17. Waters B., Lapierre Y., Gagnon A., Cahudhry R., Tremblay A., Sarantidis D., and Gray R. Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder. Biol. Psychiatry 17 (1982) 1323-1329
18. Yatham L.N., Kennedy S.H., O'Donovan C., Parikh S.V., MacQueen G., McIntyre R.S., Sharma V., Beaulieu S., Guidelines Group, and CANMAT. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord. 8 (2006) 721-739
19. Young A.H., and Hammond J.M. Lithium in mood disorders: increasing evidence base, declining use?. Br. J. Psychiatry 191 (2007) 474-476